Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 115

    1.

    Comparison of the specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia.

    St John DJ, Young GP, McHutchison JG, Deacon MC, Alexeyeff MA.

    Ann Intern Med. 1992 Sep 1;117(5):376-82.PMID: 1503328 [PubMed - indexed for MEDLINE]Related articles

    2.

    Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.

    Ahlquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, Mailliard JA, Gerstner JB, Pandya K, Ellefson RD.

    JAMA. 1993 Mar 10;269(10):1262-7.PMID: 8437303 [PubMed - indexed for MEDLINE]Related articles

    3.

    Evaluation of new occult blood tests for detection of colorectal neoplasia.

    St John DJ, Young GP, Alexeyeff MA, Deacon MC, Cuthbertson AM, Macrae FA, Penfold JC.

    Gastroenterology. 1993 Jun;104(6):1661-8.PMID: 8500724 [PubMed - indexed for MEDLINE]Related articles

    4.

    Patterns of occult bleeding in asymptomatic colorectal cancer.

    Ahlquist DA, McGill DB, Fleming JL, Schwartz S, Wieand HS, Rubin J, Moertel CG.

    Cancer. 1989 May 1;63(9):1826-30.PMID: 2702590 [PubMed - indexed for MEDLINE]Related articles

    5.

    Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia.

    Rozen P, Knaani J, Samuel Z.

    Dig Dis Sci. 1997 Oct;42(10):2064-71.PMID: 9365136 [PubMed - indexed for MEDLINE]Related articles

    6.

    Fecal alpha 1-antitrypsin detection of colorectal neoplasia. An evaluation using HemoQuant.

    Moran A, Robinson M, Lawson N, Stanley J, Jones AF, Hardcastle JD.

    Dig Dis Sci. 1995 Dec;40(12):2522-5.PMID: 8536506 [PubMed - indexed for MEDLINE]Related articles

    7.

    Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.

    Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME; Colorectal Cancer Study Group.

    N Engl J Med. 2004 Dec 23;351(26):2704-14.PMID: 15616205 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Stool DNA and occult blood testing for screen detection of colorectal neoplasia.

    Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL.

    Ann Intern Med. 2008 Oct 7;149(7):441-50, W81.PMID: 18838724 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Screening of first degree relatives of patients operated for colorectal cancer: evaluation of fecal calprotectin vs. hemoccult II.

    Kristinsson J, Nygaard K, Aadland E, Barstad S, Sauar J, Hofstad B, Stray N, Stallemo A, Haug B, Ugstad M, Tøn H, Fuglerud P.

    Digestion. 2001;64(2):104-10.PMID: 11684824 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cost effectiveness of HemoQuant versus Hemoccult for colorectal cancer screening.

    Joseph AM, Crowson TW, Rich EC.

    J Gen Intern Med. 1988 Mar-Apr;3(2):132-8.PMID: 3128650 [PubMed - indexed for MEDLINE]Related articles

    11.

    Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.

    Hundt S, Haug U, Brenner H.

    Ann Intern Med. 2009 Feb 3;150(3):162-9.PMID: 19189905 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population.

    Wong BC, Wong WM, Cheung KL, Tong TS, Rozen P, Young GP, Chu KW, Ho J, Law WL, Tung HM, Lai KC, Hu WH, Chan CK, Lam SK.

    Aliment Pharmacol Ther. 2003 Nov 1;18(9):941-6.PMID: 14616158 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.
    15.

    Comparison of three faecal occult blood tests in the detection of colorectal neoplasia.

    Hope RL, Chu G, Hope AH, Newcombe RG, Gillespie PE, Williams SJ.

    Gut. 1996 Nov;39(5):722-5.PMID: 9014773 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma.

    Tibble J, Sigthorsson G, Foster R, Sherwood R, Fagerhol M, Bjarnason I.

    Gut. 2001 Sep;49(3):402-8.PMID: 11511563 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.

    Greenberg PD, Bertario L, Gnauck R, Kronborg O, Hardcastle JD, Epstein MS, Sadowski D, Sudduth R, Zuckerman GR, Rockey DC.

    Am J Gastroenterol. 2000 May;95(5):1331-8.PMID: 10811348 [PubMed - indexed for MEDLINE]Related articles

    18.

    A quantitative immunochemical fecal occult blood test for colorectal neoplasia.

    Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Leshno M, Niv Y.

    Ann Intern Med. 2007 Feb 20;146(4):244-55.PMID: 17310048 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A comparison of fecal occult-blood tests for colorectal-cancer screening.

    Allison JE, Tekawa IS, Ransom LJ, Adrain AL.

    N Engl J Med. 1996 Jan 18;334(3):155-9.PMID: 8531970 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

    Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV.

    J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. Epub 2007 Sep 25.PMID: 17895475 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data